CytoSorbents Corporation (CTSO)

[BuyMyAsk]

As i have stated over the past 7 years, since the MSBT days. The Company CANNOT GATHER STATISTICAL SIGNIFICANT DATA showing patients benefit from being on the filter in terms of (i) 28 day mortality rates; or (ii) recovery from surgery or ICU events.

Wall Street will not buy this until then. FDA approval is years away and the Company has botched trials before, which evidences their incompetence. This should be an OTCBB stock, as when they listed on the NASDAQ the outlook was much more favorable.

I am sort of surprised the price got this low, however, the Company is nothing without FDA approval so maybe the market is starting to price the risk of not obtaining approval in teh share price.